October 29, 2025

FDA Pushes Faster, Cheaper Route for Biosimilar Approval

The FDA released new draft guidance to streamline biosimilar development.

Conexiant

October 29, 2025

Can SGLT-2 Inhibitors Shield Against Autoimmune Disease?

Researchers found sodium-glucose cotransporter-2 inhibitors lowered autoimmune rheumatic disease risk by 11% in adults with type 2 diabetes.

Conexiant

October 29, 2025

H-1B Visa Changes: Who Pays the Price?

New fee structure could hit hardest where physicians are needed most.

Conexiant

October 29, 2025

Cell and Gene Therapy: Hope, Hype and Political Upheaval

The cell and gene field has come a long way since the 1970s, but does political upheaval threaten progress?

The Medicine Maker

October 29, 2025

Rise of the Robots: Scaling Up Cell Therapies in Small Spaces

Manual processes in cell therapy manufacturing are unsustainable. Bring in the robots.

The Medicine Maker

October 27, 2025

Myelin Injury Detected Years Before MS Symptoms

Serum proteins show early immune activity years before multiple sclerosis symptoms appear.

Conexiant

October 24, 2025

A Smarter Clock for Biological Age 

Combining transcriptomic and glycomic data, a next-generation biological clock could help detect age-related disease risk long before symptoms appear 

The Analytical Scientist

October 24, 2025

Hedgehogs, Seaweed, and the Future of Cell Logistics

How biology, sustainability, and a nod to the African pygmy hedgehog are reshaping how we move living cells around the world – and beyond.

The Medicine Maker

October 23, 2025

Chest Pain & Shock After a Tuna Sandwich: What’s Your Diagnosis?

A 30-year-old man with no prior medical history developed cardiogenic shock shortly after eating a tuna sandwich. He experienced central, burning chest pain, diaphoresis, and generalized pruritus. His pain worsened with breathing and did not respond to nitroglycerin.

Conexiant